ICER Report: Costs of Approved CAR T-Cell Therapies Aligned With Clinical Benefit – AJMC.com Managed Markets Network
|
ICER Report: Costs of Approved CAR T-Cell Therapies Aligned With Clinical Benefit
AJMC.com Managed Markets Network CAR T-cell therapy has emerged as a novel way to treat cancer, genetically reprogramming a patient’s own white blood cells to attack tumor cells, and was recently named the American Society of Clinical Oncology’s Advance of the Year. Earlier this month … |
Alzheimer’s News Today |
Texas A&M and Celltex Partnering on a Stem Cell-related Alzheimer’s Treatment
Alzheimer’s News Today The fluid-filled sacs, which scientists call vesicles, transport material inside a cell. But cells often release them, and when this happens, they are called exosomes. Researchers at Texas A&M and Celltex plans a multiyear study on whether inflammation … |
Singularity Hub |
Cancer Vaccines May Overhaul Cancer Therapy in the Next Decade
Singularity Hub CAR–T, which genetically enhances a patient’s immune cells to better target cancers, was approved last year to treat certain types of blood cancers. “All of these immunotherapy advances are changing medical practice,” he says. And a tidal wave is … |
UPI.com |
Immunotherapy for peanut allergy safe, effective in clinical trial
UPI.com The idea of using immunotherapy for peanut allergy is not new, as previous research has shown it may be effective. In 2016, the Learning Early About Peanut Allergy trial found infants who consumed 2 grams of peanut protein three times per week led to … AR101 oral immunotherapy effective in reducing severity of peanut allergyHealio Peanut OIT Therapy Sees Success, Boosting Hope for FDA ApprovalAllergic Living Aimmune Therapeutics’ Pivotal Phase 3 PALISADE Trial of AR101 Meets Primary Endpoint in Patients With Peanut …Markets Insider PharmaTimes all 69 news articles » |